Literature DB >> 20030523

Prevalence of hyperkalemia among hemodialysis patients in Egypt.

Essam Khedr1, Saeed Abdelwhab, Magdy El-Sharkawy, Magdy El-Sharkay, Medhat Ali, Kadrey El Said.   

Abstract

INTRODUCTION: Hyperkalemia is a frequent problem in patients with end stage renal disease (ESRD) on maintenance hemodialysis and is often attributed as a cause of deaths in these patients. The aim of this study was to estimate the prevalence of hyperkalemia among Egyptian hemodialysis patients. PATIENTS AND METHODS: 400 ESRD patients on maintenance hemodialysis were enrolled in the study. They were allowed their usual diets and medications during the study periods. For all patients, history and clinical examinations and serum potassium level was measured three times--pre- and post-1st session and pre-next session--at two successive sessions of hemodialysis.
RESULTS: The results of this study showed that the prevalence of hyperkalemia was 41.2%, 6.5%, and 66.9% of pre- and post-dialysis and before the next session of dialysis, respectively. Hyperkalemia significantly correlates with potassium-rich diets, non-compliant patients, two sessions of hemodialysis per week, and constipation in ESRD patients during the study periods. Serum potassium level was significantly higher in anuric ESRD patients than those who had residual renal function, patients using acetate dialysate than those using bicarbonate dialysate, and patients with low blood flow rate than those with higher blood flow rates. There was a non-significant correlation between serum potassium and ACEls, B-blockers, or diabetes.
CONCLUSION: Hyperkalemia is a frequent problem in patients with end stage renal disease in Egypt. Hyperkalemia significantly correlates with a potassium-rich diet and inadequate dialysis either by prescription or non-compliance. Thrice weekly bicarbonate dialysis with higher blood pump flow rate had better elimination of potassium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20030523     DOI: 10.3109/08860220903216097

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  6 in total

Review 1.  Can Novel Potassium Binders Liberate People with Chronic Kidney Disease from the Low-Potassium Diet? A Cautionary Tale.

Authors:  David E St-Jules; Deborah J Clegg; Biff F Palmer; Juan-Jesus Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2021-10-20       Impact factor: 8.237

2.  Hyperkalemia of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in hemodialysis: a meta-analysis.

Authors:  Qian Zhang; Hong Luan; Le Wang; Miao Zhang; Yan Chen; Yongman Lv; Zufu Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10-18

3.  Metabolic and volume status evaluation of hemodialysis patients with and without residual renal function in the long interdialytic interval.

Authors:  Lenina Ludimila Sampaio de Almeida; Luís Henrique Bezerra Cavalanti Sette; Fernando Luiz Affonso Fonseca; Leila Silveira Vieira da Silva Bezerra; Francisco Hélio Oliveira Júnior; Ronaldo Roberto Bérgamo
Journal:  J Bras Nefrol       Date:  2019 Oct-Dec

4.  The effect of hyperkalemia and long inter-dialytic interval on morbidity and mortality in patients receiving hemodialysis: a systematic review.

Authors:  Danai Bem; Daniel Sugrue; Ben Wilding; Ina Zile; Karin Butler; David Booth; Eskinder Tafesse; Phil McEwan
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

5.  Inpatient management and post-discharge outcomes of hyperkalemia.

Authors:  Jill Davis; Rubeen Israni; Fan Mu; Erin E Cook; Harold Szerlip; Gabriel Uwaifo; Vivian Fonseca; Keith A Betts
Journal:  Hosp Pract (1995)       Date:  2021-05-26

6.  Potassium balances in maintenance hemodialysis.

Authors:  Hoon Young Choi; Sung Kyu Ha
Journal:  Electrolyte Blood Press       Date:  2013-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.